EMBL in Italy 2021: A Brave New World of RNA, 20-21 May 2021
Virtual at the Italian Institute of Technology (IIT), Genoa

iit

EMBL and IIT invite all students, fellows, researchers, professors and senior scientists from academia and industry to the virtual 2021 EMBL in Italy event at the Italian Institute of Technology (IIT) in Genoa on 20-21 May 2021.

  • Hear about the latest developments in RNA biology and technologies from thought leaders in academia and industry
  • Make valuable new contacts from EMBL Rome and externally
  • Network with EMBL alumni
  • Learn more about EMBL resources available to life scientists in Italy and elsewhere.

This free event is open to all and includes virtual tours of EMBL Rome and IIT.

Programme

Programme

Day 1:

Thursday 20 May

Join Zoom

13:30-14:00

Welcome from the organisers: EMBL and IIT
Host: Mehrnoosh Rayner, Head of Alumni Relations, EMBL

  • Giorgio Metta, Scientific Director, IIT, Genoa
  • Cornelius Gross, Interim Head & Senior Scientist, EMBL Rome, Monterotondo
  • Stefano Gustincich, Associate Director for Technologies for Life Science (LifeTech) – Director Central RNA Lab at IIT, Genoa

14:00-14:50

Session 1: Non-coding RNAs in Health and Disease
Host: Irene Bozzoni, Professor, IIT & Sapienza University, Rome

  • Ana Boskovic, Group Leader, EMBL Rome
    “Small RNAs-transferring information between generators”
  • Gian Gaetano Tartaglia, Group Leader, IIT, Genoa & Sapienza University, Rome
    “Non-coding RNAs and phase separation rule the world”
14:50-15:00

Break

15:00-15:30

  • Andrea Carfi
    VP and Head of Research, Infectious Disease at Moderna, Boston

15:30-16:00

Keynote speaker 
Host: Irene Bozzoni, Professor, IIT & Sapienza University, Rome
  • Adrian Krainer, St. Giles Foundation Professor & Deputy Director of Programs, CSHL Cancer Research Center Cold Spring Harbor Laboratory
    “From Base Pairs to Bedside: Antisense Modulation of RNA Splicing”
16:00-16:15 7 Flash talks – 1 minute each
  • Mara Maldotti, Postdoc, University of Turin
    "The acetyltransferase p300 is recruited to enhancers by lncRNAs via triple
    helix formation"
  • Michela A. Denti, Associate Professor, University of Trento
    “A therapeutic approach for 4R tauopathies based on siRNAs switching Tau
    splicing isoforms”
  • Sara Formichetti, Ph.D Student, EMBL Rome
    “The role of O-GlcNAcylation in mammalian transcriptional regulation”
  • Jacopo Manigrasso, Ph.D Student, IIT
    “Functional Dynamics of Pre-mRNA Splicing Unveiled at Atomic Resolution”
  • Eleonora Perego Postdoc, IIT
    “Fluorescence Fluctuation Spectroscopy with a SPAD array detector to
    unravel the dynamics of RNA in living cells”
  • Carmela Rubolino, Postdoc, IIT
    “Target-Directed miRNA degradation in breast cancer”
  • Gloria Ferrari Bravo, PhD Student, University of Trieste
    “An evolutionarily conserved pathway dependent on the prolyl-isomerase PIN1 protects the genome”

16:15-16:50

Keynote speaker
Host: Roberto Di Lauro, Professor Emeritus, University of Naples
(EMBL Group Leader, 1986-1991; EMBL SAC Member, 2005-2011)
  • Iain Mattaj, Director, Human Technopole, Milan (EMBL Director General, 2005-2018)
    “How RNA got me to Human Technopole

Join Spatial Chat

16:50-18:00

Poster Sessions
Presentation of IIT, Virtual Tours of EMBL Core Facilities and Networking with participants and speakers
Day 2:
Friday 21 May

Join Zoom

09:00-10:00

Session 2: RNA in Disease Prevention and Therapy - part 1
Host: Juergen Bauer, Deputy Managing Director, EMBLEM, Heidelberg

  • Ennio De Gregorio, Head of Research & Development Center, GSK Vaccines, Siena
    (EMBL Predoctoral Fellow, 1996-1999)
    “RNA vaccine platforms”
  • Lucia Faccio, Partner, Sofinnova-Telethon Fund, Sofinnova Partners, Milan
    “Sofinnova Partners: two decades of investment in outstanding Italian science”
10:00-10:10 Break

Join Spatial Chat

10:10-11:10

Poster Session / Presentation of IIT/ Virtual Tours of EMBL Core Facilities
and Networking with participants and speakers

Join Zoom

11:10-11:35

Session 2: RNA in Disease Prevention and Therapy - part 2
Host: Juergen Bauer, Deputy Managing Director, EMBLEM, Heidelberg

  • Patrick Baumhof, VP Formulation & Delivery, Curevac, Tübingen
    “mRNA based therapeutics: SARS-CoV-2 vaccine CVnCoV”
11:35-12:35

Panel discussion: RNA in Disease Prevention and Therapy
Moderator: Alfredo Nicosia, Professor, University of Naples (EMBL Postdoc, 1986-1990, Heidelberg)

Panel members:

  • Irene Bozzoni, Professor, IIT & Sapienza University, Rome
  • Ennio De Gregorio, GSK Vaccines, Siena
  • Juergen Bauer, EMBLEM, Heidelberg
  • Stefano Gustincich, IIT, Genova
  • Cristian Jung, Dementia Discovery Fund, London
  • Patrick Baumhof, Curevac, Tübingen
12:35-12:50

Concluding Remarks

  • Stefano Gustincich, Associate Director for Technologies for Life Science (LifeTech), Director Central RNA Lab at IIT, Genoa
  • Cornelius Gross, Interim Head of EMBL Rome, Monterotondo

Joining link

All registered participants will be sent a joining link. If you have not received yours, please contact Peter Papagiannis.

Co-organisers

  • Cornelius Gross, Interim Head & Senior Scientist, EMBL Rome
  • Stefano Gustincich, Associate Director for Technologies for Life Science (LifeTech) – Director Central RNA Lab at IIT, Genoa

Register now

Please cick here to register